Clinical Laserthermia Systems Ab Class BOMXSTO: CLS_B

Clinical Laserthermia Systems AB: Quarterly Trading Report 2025 Q3

Oct 3, 2025 at 3:04 PM UTC · Issued by Clinical Laserthermia Systems Ab Class B

Nordic ListingsIssuer Report

Clinical Laserthermia Systems AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=b13499515a737d1b0e7a213ca7efa7234&lang=en&src=omxlink

Earlier from Clinical Laserthermia Systems Ab Class B

CLS Raises SEK 20.9 Mln Through Full Subscription Of WarrantsSep 30, 2025
CLS_B: Record Q2 sales and improved margins drive narrowed losses and strong growth outlookAug 22, 2025
CLS_B: Revenue up 43% and operating loss halved as CLS accelerates neurosurgery commercializationMay 16, 2025
CLS_B: CLS doubled sales, improved margins, and refocused on neurosurgery for high-margin growthFeb 21, 2025

All Clinical Laserthermia Systems Ab Class B news releases